• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma.老年弥漫性大B细胞淋巴瘤患者的管理策略
Eur Oncol Haematol. 2012 May;8(2):123-126. doi: 10.17925/eoh.2012.08.02.123.
2
Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registry.老年（≥60岁）弥漫性大B细胞淋巴瘤患者的自体干细胞移植：基于欧洲血液与骨髓移植登记处数据的分析
Haematologica. 2008 Dec;93(12):1837-42. doi: 10.3324/haematol.13273. Epub 2008 Oct 6.
3
A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.老年弥漫性大B细胞淋巴瘤患者的宿主依赖性预后模型
Oncologist. 2017 May;22(5):554-560. doi: 10.1634/theoncologist.2016-0260. Epub 2017 Apr 13.
4
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.老年弥漫性大B细胞淋巴瘤患者中，CHOP化疗联合利妥昔单抗与单纯CHOP化疗的比较。
N Engl J Med. 2002 Jan 24;346(4):235-42. doi: 10.1056/NEJMoa011795.
5
[Comparison the efficacy and prognosis of different first-line treatment for elderly diffuse large B-cell lymphoma].[比较老年弥漫性大B细胞淋巴瘤不同一线治疗的疗效及预后]
Zhonghua Zhong Liu Za Zhi. 2020 Mar 23;42(3):234-241. doi: 10.3760/cma.j.cn112152-20190705-00413.
6
Treatment of diffuse large B-cell lymphoma in the elderly: strategies integrating oncogeriatric themes.老年弥漫性大B细胞淋巴瘤的治疗：整合老年肿瘤学主题的策略
Curr Oncol Rep. 2008 Sep;10(5):412-9. doi: 10.1007/s11912-008-0063-2.
7
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.高龄弥漫性大 B 细胞淋巴瘤患者的治疗策略和疗效。
Cancer. 2016 Oct 15;122(20):3145-3151. doi: 10.1002/cncr.30173. Epub 2016 Jun 28.
8
Validation and Refinement of the Age, Comorbidities, and Albumin Index in Elderly Patients with Diffuse Large B-Cell Lymphoma: An Effective Tool for Comprehensive Geriatric Assessment.老年弥漫大 B 细胞淋巴瘤患者的年龄、合并症和白蛋白指数的验证和修正：全面老年评估的有效工具。
Oncologist. 2018 Jun;23(6):722-729. doi: 10.1634/theoncologist.2017-0361. Epub 2018 Jan 9.
9
Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.老年 EBV 阳性弥漫性大 B 细胞淋巴瘤-来自土耳其单中心的经验。
Pathol Res Pract. 2013 Aug;209(8):471-8. doi: 10.1016/j.prp.2013.04.014. Epub 2013 May 9.
10
Rituximab: a review of its use in chronic lymphocytic leukaemia, low-grade or follicular lymphoma and diffuse large B-cell lymphoma.利妥昔单抗：在慢性淋巴细胞白血病、低级别或滤泡性淋巴瘤以及弥漫性大 B 细胞淋巴瘤中的应用综述。
Drugs. 2010 Jul 30;70(11):1445-76. doi: 10.2165/11201110-000000000-00000.

引用本文的文献

1
Diffuse Large B-Cell Lymphoma Treated With R-CHOP in a Resource-Limited Setting in South Africa: A Real-World Study.南非资源有限环境下用 R-CHOP 治疗弥漫性大 B 细胞淋巴瘤的真实世界研究。
Oncologist. 2023 Sep 7;28(9):e756-e764. doi: 10.1093/oncolo/oyad069.
2
EBV Latency III-Transformed B Cells Are Inducers of Conventional and Unconventional Regulatory T Cells in a PD-L1-Dependent Manner.EBV 潜伏期 III 转化的 B 细胞以 PD-L1 依赖的方式诱导常规和非常规调节性 T 细胞。
J Immunol. 2019 Sep 15;203(6):1665-1674. doi: 10.4049/jimmunol.1801420. Epub 2019 Aug 21.
3
Efficacy and tolerability of anthracycline-based therapy in elderly patients with diffuse large B-cell lymphoma.蒽环类药物为基础的治疗方案用于老年弥漫性大B细胞淋巴瘤患者的疗效及耐受性
Clin Lymphoma Myeloma Leuk. 2015 May;15(5):270-7. doi: 10.1016/j.clml.2014.12.011. Epub 2014 Dec 31.

本文引用的文献

1
Cancer statistics, 2012.癌症统计数据，2012 年。
CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29. doi: 10.3322/caac.20138. Epub 2012 Jan 4.
2
The proportion of activated B-cell like subtype among de novo diffuse large B-cell lymphoma increases with age.初发性弥漫性大B细胞淋巴瘤中活化B细胞样亚型的比例随年龄增长而增加。
Haematologica. 2011 Dec;96(12):1888-90. doi: 10.3324/haematol.2011.050617. Epub 2011 Aug 22.
3
Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.每周两次利妥昔单抗、环磷酰胺、长春新碱、非聚乙二醇化脂质体阿霉素和泼尼松（R-COMP-14）治疗老年高危弥漫性大 B 细胞淋巴瘤和中高危“生命威胁”型心肌病患者。
Br J Haematol. 2011 Sep;154(5):579-89. doi: 10.1111/j.1365-2141.2011.08786.x. Epub 2011 Jun 28.
4
Higher response to lenalidomide in relapsed/refractory diffuse large B-cell lymphoma in nongerminal center B-cell-like than in germinal center B-cell-like phenotype.非生发中心 B 细胞样弥漫大 B 细胞淋巴瘤对来那度胺的反应高于生发中心 B 细胞样表型。
Cancer. 2011 Nov 15;117(22):5058-66. doi: 10.1002/cncr.26135. Epub 2011 Apr 14.
5
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.80 岁以上弥漫性大 B 细胞淋巴瘤患者的减毒免疫化疗方案（R-miniCHOP）：一项多中心、单臂、2 期临床试验。
Lancet Oncol. 2011 May;12(5):460-8. doi: 10.1016/S1470-2045(11)70069-9. Epub 2011 Apr 7.
6
Novel agents for diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤的新型药物。
Expert Opin Investig Drugs. 2011 May;20(5):669-80. doi: 10.1517/13543784.2011.565745. Epub 2011 Mar 28.
7
Bortezomib plus CHOP-rituximab for previously untreated diffuse large B-cell lymphoma and mantle cell lymphoma.硼替佐米联合 CHOP-利妥昔单抗方案治疗初治弥漫性大 B 细胞淋巴瘤和套细胞淋巴瘤。
J Clin Oncol. 2011 Feb 20;29(6):690-7. doi: 10.1200/JCO.2010.31.1142. Epub 2010 Dec 28.
8
A decade of progress in lymphoma: advances and continuing challenges.淋巴瘤研究进展十年：成就与持续挑战。
Clin Lymphoma Myeloma Leuk. 2010 Dec;10(6):414-23. doi: 10.3816/CLML.2010.n.086.
9
Improving outcomes for patients with diffuse large B-cell lymphoma.提高弥漫性大 B 细胞淋巴瘤患者的治疗效果。
CA Cancer J Clin. 2010 Nov-Dec;60(6):393-408. doi: 10.3322/caac.20087. Epub 2010 Oct 28.
10
Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI).在美国 Intergroup 研究（ECOG 4494，CALGB 9793）中，比较接受 R-CHOP 治疗的 60 岁以上弥漫性大 B 细胞淋巴瘤患者的传统预后指标：老年预后指数（E-IPI）中对年龄大于 70 岁的考虑。
Br J Haematol. 2010 Oct;151(2):143-51. doi: 10.1111/j.1365-2141.2010.08331.x.

Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma.

作者信息

Nastoupil Loretta J, Sinha Rajni, Flowers Christopher R

机构信息

Department of Hematology and Oncology, Winship Cancer Institute, 1365 Clifton Road, N.E. Building B, Suite 4302, Emory University, Atlanta, GA 30322.

出版信息

Eur Oncol Haematol. 2012 May;8(2):123-126. doi: 10.17925/eoh.2012.08.02.123.

DOI:10.17925/eoh.2012.08.02.123
PMID:23805375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3690666/
Abstract
摘要